CIA
LLY icon

Cladis Investment Advisory’s Eli Lilly LLY Stock Holding History

Cladis Investment Advisory’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.97M Buy
4,143
+1
+0% +$1.02K 2.32% 6
2026
Q1 		$3.81M Sell
4,142
-510
-11% -$517K 2.1% 7
2025
Q4 		$5M Sell
4,652
-7
-0.2% -$6.69K 2.74% 4
2025
Q3 		$3.56M Buy
4,659
+15
+0.3% +$11.2K 2.03% 7
2025
Q2 		$3.62M Hold
4,644
– – 2.27% 6
2025
Q1 		$3.84M Hold
4,644
– – 2.78% 5
2024
Q4 		$3.59M Sell
4,644
-300
-6% -$248K 2.54% 5
2024
Q3 		$4.38M Sell
4,944
-900
-15% -$809K 3.04% 4
2024
Q2 		$5.29M Hold
5,844
– – 3.84% 3
2024
Q1 		$4.55M Sell
5,844
-1,017
-15% -$724K 3.34% 3
2023
Q4 		$4M Sell
6,861
-100
-1% -$58.4K 3.14% 3
2023
Q3 		$3.74M Buy
6,961
+44
+0.6% +$22.7K 3.28% 2
2023
Q2 		$3.24M Hold
6,917
– – 2.82% 3
2023
Q1 		$2.38M Buy
6,917
+30
+0.4% +$10.1K 2.13% 5
2022
Q4 		$2.52M Sell
6,887
-230
-3% -$81.5K 2.51% 3
2022
Q3 		$2.3M Buy
7,117
+47
+0.7% +$14.9K 2.49% 3
2022
Q2 		$2.29M Hold
7,070
– – 2.29% 4
2022
Q1 		$2.02M Sell
7,070
-500
-7% -$129K 1.64% 14
2021
Q4 		$2.09M Buy
+7,570
New +$1.92M 1.68% 12

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Cladis Investment Advisory's LLY Position: Q2 2026 in Review

Cladis Investment Advisory increased its Eli Lilly (LLY) stake by 0.02% in Q2 2026, buying an estimated $1.02K and bringing the position to 4,143 shares worth $4.97M. The position accounts for 2.32% of the portfolio, ranked #6.

Cladis Investment Advisory first reported a position in LLY in Q4 2021 and has held it in 19 quarters since. The position peaked at $5.29M in Q2 2024. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Cladis Investment Advisory held 4,143 shares of Eli Lilly worth $4.97M as of Q2 2026.
  • Cladis Investment Advisory bought 1 Eli Lilly share in Q2 2026, an estimated $1.02K.
  • Eli Lilly made up 2.32% of Cladis Investment Advisory's portfolio in Q2 2026, its #6 holding.
  • Cladis Investment Advisory first reported a position in Eli Lilly in Q4 2021 and has held it in 19 quarters since.
  • Cladis Investment Advisory's Eli Lilly position peaked at $5.29M in Q2 2024.
  • 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Cladis Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.